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Distribution and Dynamics of Laser-Polarized 129Xe
Magnetization In Vivo
Scott D. Swanson,1* Matthew S. Rosen,2 Kevin P. Coulter,2 Robert C. Welsh,2
and Timothy E. Chupp2
The first magnetic resonance imaging studies of laser-polarized
129Xe, dissolved in the blood and tissue of the lungs and the
heart of Sprague-Dawley rats, are described. 129Xe resonances
at 0, 192, 199, and 210 ppm were observed and assigned to
xenon in gas, fat, tissue, and blood, respectively. One-dimen-
sional chemical-shift imaging (CSI) reveals xenon magnetiza-
tion in the brain, kidney, and lungs. Coronal and axial two-
dimensional CSI show 129Xe dissolved in blood and tissue in the
thorax. Images of the blood resonance show xenon in the lungs
and the heart ventricle. Images of the tissue resonance reveal
xenon in lung parenchyma and myocardium. The 129Xe spec-
trum from a voxel located in the heart ventricle shows a single
blood resonance. Time-resolved spectroscopy shows that the
dynamics of the blood resonance match the dynamics of the gas
resonance and demonstrates efficient diffusion of xenon gas to
the lung parenchyma and then to pulmonary blood. These
observations demonstrate the utility of laser-polarized 129Xe to
detect exchange across the gas-blood barrier in the lungs and
perfusion into myocardial tissue. Applications to measurement
of lung function, kidney perfusion, myocardial perfusion, and
regional cerebral blood flow are discussed. Magn Reson Med
42:1137–1145, 1999. r 1999 Wiley-Liss, Inc.
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The biological properties of xenon and the ability to create
high levels of nuclear polarization in noble gases combine
to make magnetic resonance imaging (MRI) of laser-
polarized 129Xe an exciting field of research. Freely diffus-
ible across biological membranes and metabolically inert,
xenon dissolves in blood (1), travels to distant organs,
and accumulates in tissue. By applying the principles
of diffusible indicators first outlined by Kety (2), radio-
active 133Xe has been used in nuclear medicine to mea-
sure kidney perfusion (3), cardiac perfusion (4), regional
cerebral blood flow (rCBF) (5), and lung ventilation
(6). These measurements are possible because the tissue
distribution (7) and dynamics of 133Xe in vivo are well
understood. To make similar perfusion measurements us-
ing MRI of laser-polarized 129Xe, the distribution and
dynamics of xenon magnetization in vivo must first be
determined.
The most exciting medical applications for laser-
polarized (also called hyperpolarized) 129Xe nuclear mag-
netic resonance (NMR) lie in imaging xenon dissolved in
tissue or blood. Previous spectroscopy studies of 129Xe in
vivo in the mouse body (8), rat body (9), rat brain (10,11),
and human brain and chest (12) demonstrated that xenon
in blood, tissue, and gas resonates at different frequencies
and suggest that the different frequency components can be
selectively imaged. In vitro studies of xenon dissolved in
blood have revealed two components, plasma and red
blood cell, exchanging rapidly with respect to T1 but
slowly with respect to the inverse frequency separation
(13,14). Additional in vitro work has measured the T1 of
xenon dissolved in tissue samples (15). Our initial work
focused on imaging 129Xe in the rat brain after inhalation
and resulted in the first, chemical-shift resolved image of
laser-polarized 129Xe dissolved in tissue (10). No informa-
tion has been published to date concerning the spatial
distribution of xenon magnetization in the whole body in
vivo.
The tissue distribution of 129Xe magnetization in vivo
will be much different than the distribution of xenon (7)
because xenon polarization decays once injected or in-
haled. The value of the decay rate differs in the lungs,
blood, tissue, and fat. Measuring the xenon magnetization
distribution is needed to determine which organs will be
suitable for perfusion measurement with laser-polarized
129Xe. Understanding the dynamics of 129Xe magnetization
in vivo is essential to new imaging methods that measure
tissue perfusion with MRI of laser-polarized 129Xe. This
paper presents the first chemical-shift resolved images of
129Xe in blood, tissue, and gas in the thorax, assignments
for the in vivo blood and tissue resonances, and a study of
the dynamics of laser-polarized 129Xe in vivo. We also
discuss how MRI of laser-polarized 129Xe may be used in
the future to measure rCBF, cardiac perfusion, kidney
perfusion, and lung function.
MATERIALS AND METHODS
Xenon Polarization and Delivery
Xenon was polarized and delivered to Sprague-Dawley rats
(200–250 g) by an apparatus previously described (10) and
recently modified (11). The current device makes multiple,
165-ml batches of laser-polarized, naturally-abundant xe-
non (129Xe 26.44%) at a rate of approximately one batch per
5 minutes. 129Xe polarization is typically 5%. Each batch
was frozen and stored as xenon ice (T1 > 1 hour at 50 mT
and 77 K). Between two and five batches of polarized 129Xe
were used for each experiment presented here. After
freezing of multiple batches, polarized xenon ice was
warmed, and the gas expanded into a one-liter glass
cylinder sealed by a Teflon piston. A series of automated
valves regulated delivery of a 50/50 xenon/oxygen mixture
to the animal. Mixing with oxygen occurred just before
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inhalation, thereby reducing destruction of xenon magneti-
zation by paramagnetic oxygen (16). Animals were venti-
lated on the xenon/oxygen mixture for up to 4 minutes at
80 breaths per minute.
Animal and Imaging Procedures
All animal procedures were performed under a protocol
approved by the University Committee on the Use and Care
of Animals (UCUCA). Three male Sprague-Dawley rats
(200–250 g) were used for these studies. Each rat was
initially anesthetized with an intraperitoneal injection of
ketamine/xylazine mixture (43 mg/kg ketamine, 6 mg/kg
xylazine). A 16-gauge, 2.5-inch endotracheal tube was
placed and anchored with suture. The animals were venti-
lated with 2.4 ml per breath of oxygen with a small animal
ventilator (Harvard Apparatus, South Natick, MA) at 80
breaths per minute. Anesthesia was maintained with halo-
thane (0.5–1.5%) using a calibrated vaporizer (Fluotec,
Buffalo, NY). Pulse rate and oxygen saturation were con-
tinuously monitored with a pulse oximeter (Nonin, Ply-
mouth, MN) via a photo transducer pair placed on the tail.
Body temperature was maintained at 37°C by a warm water
blanket beneath the animal. The rat was placed supine on
the experimental platform in a doubly-tuned 1H-129Xe
volume probe. The entire assembly of animal, probe, and
delivery valve was placed into the magnet during NMR
study. Xenon was polarized, stored, and delivered to the
animal as previously described (10). Oxygen saturation
typically started between 92% and 95%, dropped to 88%
during the first minute of xenon/oxygen inhalation, and
then returned to 92% for the remaining 3 minutes. Heart
rate remained relatively constant throughout xenon/
oxygen inhalation. After 129Xe inhalation and study, the
animal was switched back to breathing O2, and the probe
was switched for proton imaging. After a number of 129Xe
experiments, the animal was euthanized with an overdose
of pentobarbital.
NMR Methods
All experiments were performed on a 2.0 T Omega CSI
manufactured by General Electric (Fremont, CA) and
equipped with self-shielded gradients. A doubly-tuned,
slotted-cylinder NMR probe was constructed to resonate at
the 129Xe and 1H frequencies, enabling registration of
xenon chemical-shift imaging (CSI) data with proton im-
ages (17). The probe is 14.5 cm long and 6.0 cm in diameter.
To estimate the NMR tip angle, a, the transverse 129Xe
magnetization was measured in a closed glass vessel as a
function of the number, n, of RF pulses. The decay of
transverse magnetization was fitted by the function
Mx(n,a) 5 sin (a)cosn21(a)M0.
Spectroscopy
Spectra of laser-polarized 129Xe in the rat body are shown
in Fig. 1. Data collection began before introduction of
laser-polarized 129Xe (see Fig. 7) and continued throughout
the approximately 40-second xenon inhalation. The full
spectrum in Fig. 1 is the sum of three datasets, obtained
from one animal, each with 40 seconds of xenon/oxygen
breathing. The tip angle was 13°, the pulse width 10 µs, the
spectral width 10 kHz, and the block size 1 k. All spectra
and images in these studies were cardiac gated and ac-
quired with an effective repetition time (TR) of 428 ms (two
cardiac cycles at 280 beats per minute). The time domain
data were multiplied by an exponential line-broadening
function of 20 Hz before Fourier transformation and phas-
ing.
The spectrum shown in the inset of Fig. 1 was acquired
with similar parameters. To minimize destruction of xenon
magnetization in the gas phase, a 200-µs radiofrequency
(RF) pulse was used, and the frequency of the spectrometer
was shifted so that the peaks around 200 ppm were on
resonance. This procedure places the gas resonance near
the null point in the frequency excitation profile of the RF
pulse. The tip angle was measured to be 30° for the
blood/tissue resonances and estimated to be approxi-
mately 1° for the gas resonance. The spectrum in the Fig. 1
inset was acquired from a single experiment of about 25
seconds’ breathing of the xenon/oxygen mixture.
One-Dimensional CSI
One-dimensional chemical-shift images were collected
along the anterior-posterior axis of the animal. Localized
129Xe spectra from 220 to 180 ppm are shown in Fig. 2 and
reveal xenon dissolved in blood, tissue, and fat. Two
experiments were performed: one with a 30° tip angle and
FIG. 1. In vivo NMR spectra of 129Xe in the rat body. The full
spectrum shows 129Xe dissolved in blood, tissue, and fat at 210, 199
and 192 ppm, respectively. Xenon gas in lungs is set to 0 ppm. The tip
angle used to acquire the full spectrum was 13°, allowing magnetiza-
tion to build up in tissue and causing the tissue resonance to be larger
than the blood resonance. The inset shows a spectrum of the
blood/tissue resonances acquired from another experiment with a tip
angle of 30°. The tissue component is relatively smaller in the inset
spectrum and the blood resonance correspondingly larger because
the magnetization is sampled (and destroyed) in the blood before
perfusing to distant organs.
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the other with a 13° tip angle as indicated in Fig. 2. The
field-of-view (FOV) for each experiment was 180 mm with
64 phase-encoding steps. The duration of the phase-encode
gradient was 500 µs. All other parameters are as in the Fig.
1 inset. No slice selection was used in these one-
dimensional (1D) CSI experiments. Xenon delivery com-
menced about 5 seconds before the start of the pulse
sequence and continued throughout the 1-minute acquisi-
tion.
The data were processed with 20-Hz line broadening in
the time domain and a trapezoidal function in k space. The
kz dimension was zerofilled from 64 to 128 data points. The
data were Fourier transformed in both dimensions and are
presented as a grayscale image in phase-sensitive mode in
Fig. 2. A series of spin-echo proton images with 2-mm slice
thickness (TR 428 ms, TE 18 ms, FOV 180 mm) was
recorded for anatomical registration of the localized 129Xe
spectra. Slices of proton images containing brain, kidney,
and heart are shown in Fig. 2.
The regions labeled A, B, and C on Fig. 2 in the 13° 1D
CSI experiment were summed over the spatial regions as
indicated by the boxes. The spectra corresponding to the
boxed regions are shown in Fig. 3 a, b, and c.
Two-Dimensional CSI
Axial and coronal images of xenon in blood, tissue, and gas
are shown in Figs. 4 and 5. Figure 4 shows the grayscale
xenon and proton images, and Fig. 5 shows a false color
rendition of the xenon images superimposed on the proton
images for anatomical registration. Xenon was delivered to
the animal for approximately 4 minutes, during which
time data were acquired. Each dataset was acquired with
16 3 16 phase-encoded values and two averages per
phase-encode line. The FOV was 60 3 60 mm in the axial
images (Fig. 4 A–D and Fig. 5 A–C) and 100 3 100 mm in
the coronal images (Fig. 4 E–H and Fig. 5 D–F). The axial
xenon images were created from a single dataset with a
4-minute signal acquisition, and the coronal images were
created from the sum of two 4-minute acquisitions. No
slice selection was used. With a 30° tip angle and a 428-ms
TR, xenon magnetization is sampled and destroyed in the
thorax before it can perfuse to the brain or kidney (see the
1D CSI data shown in Fig. 2). Other parameters are as in the
Fig. 1 inset.
Each dataset was multiplied by a 20-Hz line broadening
function in the time domain and a trapezoidal function in
both kx and kz or kx and ky. k-Space was zerofilled from
16 3 16 to 32 3 32. The data were then Fourier transformed
along each dimension and the magnitude was calculated.
Summing the two-dimensional (2D) planes across each
resonance (blood, tissue, and gas) created images shown in
Figs. 4 and 5. Cardiac-gated proton images, with an appro-
priate FOV, were collected for spatial registration of the
129Xe signal. Water from the warming blanket is seen on the
top in Fig. 4D and Fig. 5 A–C.
FIG. 2. One-dimensional CSI of 129Xe dissolved in blood, tissue, and fat in the rat body and 1H spin-echo images for anatomical registration.
CSI data of the blood and tissue resonances (from 220 to 180 ppm) are presented as grayscale images. Results of two experiments at 30° and
13° tip angle are presented. With a 13° tip angle, sufficient magnetization accumulates in the brain and kidney. With a tip angle of 30°, 129Xe
magnetization is sampled and destroyed in the thorax before it has a chance to reach the brain or kidney. The resonance at 192 ppm is present
only near the heart and hence is assigned to xenon dissolved in epicardial fat. The boxes labeled A, B, and C correspond to the regions used to
construct the localized spectra in Fig. 3.
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Two representative 129Xe spectra from the axial 2D CSI
dataset, displayed on the same vertical scale, are shown in
Fig. 6. Figure 6a shows the spectrum of a voxel located near
the heart ventricle, and Fig. 6b shows the spectrum of a
voxel located in the lungs.
Dynamics
Uptake and washout of each resonance of 129Xe in the rat
body are shown in Fig. 7. A series of 64 spectra was
recorded with two phase-cycled averages each. The fre-
quency and line width of each resonance was determined
by fitting a multiple Lorentzian model to the spectrum in
the Fig. 1 inset. With these parameters fixed, the amplitude
of each peak for each of the 64 spectra was determined by
x2 minimization. This procedure assumes that the fre-
quency and width of each resonance is constant through-
out the uptake and washout. The results are shown in Fig. 7
for xenon in gas, fat, tissue, and blood. The amplitude of
the xenon gas resonance was normalized to the amplitude
FIG. 3. Localized spectra of 129Xe in the rat
body. Spectra of 129Xe from regions encom-
passing the brain (a), heart (b), and kidney
(c). Each spectrum was obtained by sum-
ming the 1D CSI data over the respective
regions indicated on Fig. 2. The tip angle in
this study was 13°.
FIG. 4. 129Xe axial (A–C) and coronal (E–G) 2D CSI. Images of 129Xe in blood (A and E), tissue (B and F), and gas (C and G) are presented.
Cardiac-gated proton images (D and H) are shown for anatomical registration. The FOV was 60 3 60 mm in the axial images (A–D) and 100 3
100 mm in the coronal images (E–H). The tip angle was 30° for all images.
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of the resonance of xenon dissolved in blood in Fig. 7a. The
magnetization of xenon dissolved in blood, tissue, and fat
are shown on the same scale in Fig. 7b. Delivery of the
xenon/oxygen mixture started at approximately t 5 5
seconds, and continued to t 5 30 seconds (Fig. 7). The tip
angle in this study was 30°. Figure 8 shows three spectra
obtained at the beginning (a), middle (b), and end (c) of
xenon delivery to the animal. Each spectrum was acquired
in 4 seconds. The tip angle used to acquire the spectra in
Fig. 8 was 13°.
FIG. 5. Color overlay of the axial (A–C) and coronal (D–F) 129Xe images onto the 1H images. Images of 129Xe dissolved in blood (A and D)
show xenon in lung vasculature and in the heart ventricle. Images of 129Xe dissolved in tissue (B and E) show xenon dissolved in the lung
parenchyma and in the myocardium. A difference between the gas images (C and F) and the blood images (A and D) can be used to assess
lung function in a single MRI study. Images of 129Xe dissolved in the myocardium can be used to create a map of myocardial perfusion.
FIG. 6. Spectra of 129Xe constructed from a
single voxel of the 2D CSI data located in the
heart ventricle (a) and lungs (b) in Sprague-
Dawley rats. Each spectrum was extracted
from the data shown in Figs. 4 and 5. The
single resonance observed in blood in the
heart ventricle at 210 ppm (a) is consistent
with fast exchange of xenon between red
blood cells and plasma.
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FIG. 7. Dynamics of 129Xe magnetization in
vivo. a: The uptake and washout of xenon
gas (d) and xenon dissolved in blood (s).
The dynamics of the blood resonance match
the dynamics of the gas resonance and
demonstrate efficient exchange of xenon
between gas and blood in the lung. b: Dynam-
ics of xenon dissolved in blood (s), tissue
(h), and fat (m). The tip angle in this experi-
ment was 30° and the TR was 428 ms.
FIG. 8. Spectra obtained at the beginning
(a), middle of (b), and end of (c) xenon gas
delivery. All spectra are plotted on the same
vertical scale and were acquired over a
period of four seconds. a: Xenon in gas,
tissue, and blood is present at the onset of
the delivery of xenon gas. The resonance of
xenon dissolved in tissue is probably caused
by xenon in lung epithelium at this early time
in the uptake. The resonance of xenon in fat
is absent. b: All three resonances are near
equilibrium, with the tissue resonance clearly
larger than either the blood or the fat reso-
nance. c: At the end of xenon delivery, the
coupled blood and gas peaks are small. The
resonances of xenon dissolved in tissue and
in fat remain. The resonance at 192 ppm,
assigned to xenon dissolved in fat, does not
appear at the onset of xenon delivery in a
and remains after the blood component has
nearly disappeared in c. The tip angle in this
experiment was 13°.
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RESULTS AND DISCUSSION
Spectroscopy
The spectra of 129Xe in the rat body shown in Fig. 1 were
acquired with tip angles of 13° (full spectrum) and 30°
(inset spectrum). The data presented here are consistent
with xenon dissolved in blood (210 ppm), xenon dissolved
in tissue (199 ppm), xenon dissolved in fat (192 ppm), and
xenon gas (0 ppm). As described above, each spectrum in
Fig. 1 represents an average, steady-state spectrum ac-
quired with repeated RF pulsing. The relative amplitudes
of xenon magnetization in blood, tissue, and gas are
different in the main spectrum and the inset in Fig. 1. The
difference arises because the larger tip angle used to
acquire the spectrum in the inset destroys xenon magneti-
zation in the blood before it has a chance to perfuse to
distant organs such as brain and kidney. The effective
transverse relaxation time, T*2, was determined by the
width of a Lorentzian fit to each resonance and found to be
approximately 2 ms for 129Xe dissolved in blood or tissue, 7
ms for 129Xe dissolved in fat, and 5 ms for 129Xe gas in the
lungs.
One-Dimensional CSI
The magnetization of laser-polarized 129Xe was localized in
the rat body with 1D CSI (Fig. 2). Spectrally resolved
images were acquired along the anterior-posterior axis of
the animal to obtain the spatial distribution of xenon
magnetization dissolved in blood, tissue, and fat. One-
dimensional CSI images show that 129Xe magnetization in
blood is present in the thorax (lungs and heart) and that
129Xe magnetization in tissue is present in the brain and
abdomen (kidney and/or liver) in addition to the thorax.
The effect of tip angle on the spatial distribution of xenon
magnetization is shown in Fig. 2. With a 13° tip angle, 129Xe
magnetization is observed in all perfused tissues. This
occurs because the rate of destruction of 129Xe magnetiza-
tion is slow compared with the rate of transfer to the tissue.
With a 30° tip angle, 129Xe magnetization is observed only
in the thorax; longitudinal magnetization is sampled and
destroyed in the thorax before it can reach the more distant
organs, such as the brain or the kidneys.
It is apparent that the resonance at 192 ppm is localized
to a region near the heart (Fig. 2) and therefore could be
caused by xenon dissolved in myocardial tissue or xenon
dissolved in fat. The data in Fig. 2 indicate that the
intensity of the signal decreases when the tip angle is
increased from 13° to 30°. Combined with the time-
resolved spectroscopic studies presented below, this is
consistent with slowly perfused adipose tissue. In addi-
tion, this resonance only appears near the heart and is
probably caused by xenon dissolved in epicardial fat.
Localized 129Xe spectra, created by summing over the
boxed regions shown in Fig. 2, are presented in Fig. 3.
Figure 3a corresponds to the boxed region of the brain
indicated in Fig. 2. Similarly, Fig. 3b corresponds to the
region of the thorax, and Fig. 3c corresponds to the region
of the kidneys. Figure 3a shows a single resolved peak in
the brain, consistent with our previous findings in the rat
brain (10,11) and with other findings in the human brain
(12). Figure 3b shows the xenon spectrum in the region of
the heart. Xenon dissolved in blood, tissue, and epicardial
fat is clearly present. Figure 3c shows a spectrum from the
abdominal region of the rat. Although this resonance could
arise from xenon in liver, fat, or kidney, it is most likely
from xenon in kidney. This conclusion is, based on the
high kidney perfusion rate, the chemical shift of the
resonance, and the spatial location of the resonance.
Two-Dimensional CSI
One-dimensional CSI experiments demonstrate that 129Xe
magnetization is present in the brain, kidney, and thorax of
Sprague-Dawley rats after inhalation of laser-polarized
129Xe gas. The 1D CSI data, together with the known
biological properties of xenon, show that it will be possible
to create quantitative maps of tissue perfusion in the brain
and kidney. To provide a clearer picture of the distribution
of xenon magnetization in the thorax, a series of 2D CSI
experiments was performed. In Figs. 4 and 5 we show the
spatial distribution of xenon magnetization in the blood,
tissue, and gas components in the thorax. Both axial and
coronal projection images were acquired. The xenon signal
was localized to the thorax by sampling the magnetization
with a 30° tip angle, as discussed above.
The images of 129Xe dissolved in blood (Figs. 4A, 4E, 5A,
and 5D) show xenon present in the lung capillary bed, the
pulmonary veins, and the left ventricle of the heart. A
strong blood signal is found throughout the lungs, indicat-
ing efficient transport of xenon from gas in the lungs to
blood in the lungs. These images of xenon in blood in the
lungs represent the first use of laser-polarized 129Xe to
measure transport of xenon gas across the lung epithelium
and into blood. Because blood is most concentrated in the
heart, the greatest signal intensity in the image of the blood
resonance arises from the xenon in blood in the left
ventricle of the heart.
The images of 129Xe gas (Figs. 4C, 4G, 5C, and 5F) show
xenon present in the air space of the lungs and trachea.
Although images constructed from CSI data may have
lower resolution than the high-resolution in vivo images of
3He gas (18), high spatial resolution is often not needed for
critical clinical decisions in pulmonary medicine. What is
needed is a measure of lung function. A difference between
the distribution of xenon in blood and gas in the lung
would show a defect, such as a pulmonary embolism. This
is an example of how 129Xe MRI could be used to assess
lung function. Thus, 129Xe CSI and other frequency-
selective imaging methods have the potential to replace
standard ventilation-perfusion techniques with a single
MRI study.
The images of xenon dissolved in tissue in the thorax
(Figs. 4B, 4F, 5B, and 5E) arise predominately from xenon
dissolved in the lung epithelium. This finding is consistent
with the spectroscopic and dynamic results presented
below that show xenon passing through a tissue phase in
the lungs before reaching the pulmonary blood. Xenon
magnetization in tissue is also observed in the region of the
heart (Figs. 4B and 5B) and indicates that xenon is present
in myocardial tissue. The presence of xenon magnetization
in the myocardium allows MRI of laser-polarized 129Xe to
be used to measure cardiac perfusion, similar to the
manner in which 133Xe signals are used in nuclear medi-
cine (4). The blood and tissue resonances in the lung are
broadened by magnetic field inhomogeneities caused by
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the air-tissue interface and may account for the relatively
broad tissue phase signals observed in the thorax. Since the
gyromagnetic ratio of 129Xe is about four times less than the
gyromagnetic ratio of 1H, susceptibility broadening is less
severe for 129Xe than for 1H.
Figure 6a shows the spectrum of a single voxel of the
axial 2D CSI dataset located near the left ventricle in the
heart. This volume consists primarily of blood. The most
prominent feature in Fig. 6a is the large, single resonance
observed at 210 ppm. Previous in vitro spectroscopic
studies show two resonances in human blood identified as
red blood cells and blood plasma (13,14). Figure 6b is the
spectrum from a voxel located in the lungs and shows
xenon in the gas, blood, and tissue of the lungs. The gas
resonance is relatively small because the gas magnetization
is tipped only 1° by the 200 µs RF pulse, whereas the blood
and tissue components are tipped approximately 30°. The
ability to monitor xenon magnetization in the gas, in the
tissue, and in the blood in the lungs may provide measures
of lung function more sensitive than those currently avail-
able with nuclear medicine techniques.
Dynamics
The dynamics of xenon magnetization in gas, blood, tissue,
and fat are presented in Figs. 7 and 8. Figure 7a shows that
xenon magnetization in blood is proportional to xenon
magnetization in gas, demonstrating exchange between the
gas and blood components in the lungs that is fast on the
time scale of 500 ms.
The uptake and washout of xenon magnetization
dissolved in blood, tissue, and fat are shown in Fig. 7b.
The amplitude of the blood resonance plateaued after
about 13 seconds of xenon delivery, but the amplitudes of
the tissue and fat resonances continued to grow and had
not yet leveled off when xenon delivery was stopped at
about 25 seconds. Organs such as the brain, the kidneys,
the liver, and the heart have more capacity for xenon
because of their blood-tissue partition coefficients and
their greater partial volume compared with blood. The
apparent uptake and washout rates of 129Xe in fat are
slightly slower than the uptake and washout rates for 129Xe
in tissue (Fig. 7), consistent with a slower perfusion rate in
fat.
The spectra shown in Fig. 8, obtained at the beginning,
middle, and end of xenon delivery, help clarify the assign-
ments of the blood and tissue resonances. At the beginning
of xenon delivery (Fig. 8a), xenon is present in blood and
tissue with the tissue resonance larger than the blood
resonance. Because the tissue resonance appears soon after
the start of xenon delivery, it most likely arises from xenon
in lung parenchyma. Similarly, the blood resonance in
Fig. 8a must be from xenon in the lung capillary bed.
Figure 8b shows the xenon spectrum just before the time
when xenon delivery has stopped. All three resonances are
present, and the tissue resonance is much larger than either
the fat or the blood resonance. After delivery of xenon gas
has stopped, the gas and blood resonances have nearly
disappeared (Fig. 8c), whereas the tissue and fat reso-
nances remain.
Assignments
The data presented here are consistent with xenon dis-
solved in blood (210 ppm), tissue (199 ppm), and fat (192
ppm). These assignments are indicated by the spatial
distribution of xenon (Figs. 2–5), the in vivo spectrum
obtained from the heart ventricle (Fig. 6a), and the dynam-
ics of xenon in vivo (Figs. 7 and 8).
Previous in vitro work has shown that 129Xe magnetiza-
tion in human blood has resonances at 216 and 192 ppm
assigned to xenon in red blood cells and xenon in plasma,
respectively (13,14). Studies at 9.4 T and ambient labora-
tory temperature found that the magnetization of these
resonances is coupled by exchange of xenon between the
two components (14). Because of exchange, one would
expect that spectra of 129Xe dissolved in blood would
always have two resonances in vivo. These findings have
led others (9) to assign the resonances of nonlocalized, in
vivo, 129Xe spectra to xenon in red blood cells (213 ppm),
xenon in tissue (199 ppm), and xenon in fat or plasma (191
ppm). We find no evidence for two blood resonances in
Sprague-Dawley rats in vivo. The spectrum of 129Xe local-
ized to the left ventricle of the heart, where the highest
concentration of blood in the thorax is present, consists of
one dominant resonance at 210 ppm (Fig. 6a). Figure 8a
shows a resonance at 210 ppm at the onset of xenon
delivery. This resonance could be assigned to xenon in red
blood cells, but no corresponding plasma resonance is
present at 192 ppm. In Fig. 8c, a resonance is present at 192
ppm but no resonance is observed at 210 ppm. Our data
require a different assignment of the resonances, as indi-
cated above.
A variety of factors could contribute to the observation of
one resonance in rat blood in vivo. Hemoglobin of Sprague-
Dawley rats may have a different affinity for xenon than
human hemoglobin and may create a different chemical
shift. The rat red blood cell is known to be smaller than the
human red blood cell (19), allowing more efficient mixing
of the two components. In the fast exchange limit, the
frequency of the blood resonance, nblood, is given by a
weighted average of the frequencies of the red blood cell
(rbc) component, nrbc, and the plasma component, nplasma:
nblood 5 prbcnrbc 1 pplasmanplasma. [1]
The coefficients prbc and pplasma, the mole fractions of xenon
in red blood cells and plasma, are determined by the red













Using previously measured values, it is possible to esti-
mate the blood resonance frequency under fast exchange
conditions. We set nrbc to 216 ppm and nplasma to 199 ppm
(as previously reported (13,14)), the hematocrit to 42%,
and lcp to 2.55. (The xenon partition coefficient is
2.27 6 0.07 in human blood and 3.31 6 0.06 in dog blood
(20)). With these parameters, Eqs. [1] and [2] yield a value
of 210 ppm for nblood, the same chemical shift as measured
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in vivo. This analysis shows that our observations are
consistent with 129Xe in fast exchange between the red
blood cell and plasma components. The data and the
analysis presented here do not explain, at a fundamental
level, the discrepancies observed between xenon in human
blood in vitro and xenon in rat blood in vivo. More work is
needed to fully understand the differences observed in
129Xe magnetization in different species and under differ-
ent experimental conditions.
The resonance at approximately 199 ppm first appears in
lung parenchyma after xenon gas is introduced into the
lungs (Fig. 8a). The tissue signal grows with time and
becomes larger than the signal of 129Xe dissolved in blood
as xenon perfuses into more distant organs such as brain
and kidney (Figs. 1 and 8b). One-dimensional CSI data
acquired with a low–tip-angle pulse show that xenon
magnetization at 199 ppm is present in the thorax, the
kidneys, and the brain (Fig. 2). Two-dimensional CSI data
show xenon magnetization at this frequency in the thorax,
in the lungs and in the heart (Figs. 4B and 5B). Our
previous work (10) has shown that the spectrum of 129Xe in
the brain is dominated by a single resonance: xenon
dissolved in brain tissue. The resonance at 199 ppm is
consistent with 129Xe magnetization dissolved in tissue.
The resonance observed at 192 ppm is assigned to xenon
in epicardial fat based on chemical shift, dynamics, and
location in the rat body, as discussed above. The chemical
shift of this resonance is similar to the chemical shift of
xenon dissolved in beef fat (9) or long-chain fatty acids
(21). Autoradiography has shown that 133Xe accumulates in
epicardial fat at steady-state (22). Because nuclear medi-
cine does not differentiate between 133Xe in myocardial
tissue and 133Xe in epicardial fat, 133Xe is currently not a
preferred method for measuring cardiac perfusion (4,23).
We have shown that 129Xe magnetization in epicardial fat
and in myocardial tissue are easily separated with NMR
methods.
CONCLUSION
The results presented here show that 129Xe magnetization
is present in lungs, blood, brain, kidney, myocardium, and
epicardial fat after inhalation of laser-polarized 129Xe. 129Xe
resonances are observed in vivo at 210, 199, and 192 ppm
and are consistent with 129Xe magnetization dissolved in
blood, tissue, and epicardial fat, respectively. 129Xe magne-
tization flows from gas in lungs, to lung epithelium, into
the blood, through the heart, and finally into organs (heart,
brain, and kidney). In the heart ventricle, a single blood
resonance is observed, indicating that the red blood cell
and plasma components are in fast exchange in vivo at
37°C and 2T in rat blood. A difference between the
distribution of 129Xe gas in the lungs and in blood in the
lungs allows assessment of lung function in a single MRI
study. In a separate paper, we show that 129Xe MRI with
appropriate RF sampling can be used to measure tissue
perfusion. Increases in 129Xe polarization from the current
5% to 8% to realistic levels of 35% will allow spatial
resolution comparable to that of standard proton MR
images.
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